Literature DB >> 26424290

Effect of Qiguiyin Decoction on multidrug-resistant Pseudomonas aeruginosa infection in rats.

Ling-Bo Kong1, Qun Ma2, Jie Gao1, Guo-Song Qiu3, Li-Xia Wang3, Shu-Min Zhao4, Yong-Gang Bao4, Qing-Quan Liu5,6.   

Abstract

OBJECTIVE: To investigate the effect of Qiguiyin Decoction, QGYD) on multidrug-resistant Pseudomonas aeruginosa infection in Sprague-Dawley (SD) rats.
METHODS: A pseudomonal infection model in SD rats was established by injecting multidrug-resistant P. aeruginosa intraperitoneally. Infected rats were randomized into four groups treated with Pure water, QGYD, ceftazidime, or combined QGYD and ceftazidime. Blood samples were obtained from the abdominal aorta. Serum was then collected and analyzed by peptide array for immune responsiveness to multidrug-resistant beta-lactamase proteins, including Verona integronen-coded metallo-beta-lactamase 1 (VIM-1), Sao Paulo metallo-beta-lactamase 1 (SPM-1), and Temoniera (TEMs). Blood levels of interleukin-1β (IL-1β), interleukin-4 (IL-4), and interferon-γ (IFN-γ) were assessed by enzyme-linked immunosorbent assay.
RESULTS: QGYD enhanced antibody reactivity against VIM-1 [epitopes 7-11 and 36-40] and TEM-1 [epitopes 26-27, 52-55, and 66-70]. QGYD treatment restored the compromised antibody reactivity against VIM-1 [epitopes 53-54 and 56-58] and SPM-1 [epitopes 16-19 and 82-85] following pseudomonal infection. Serum levels of IL-1β and Th1/Th2 in the rats were significantly elevated following pseudomonal infection (P<0.05 orP<0.01). In contrast, QGYD and combination QGYD and ceftazidime treatment restored the elevated serum IL-1β and Th1/Th2 levels to normal (P>0.05).
CONCLUSIONS: QGYD improves the immune response to pseudomonal infection in rats by stimulating the production of protective antibodies against drug-resistant proteins VIM-1, SPM-1, and TEM-1. In addition, it protects the immune system and maintains immune responsiveness by restoring IL-1β and Th1/Th2 levels.

Entities:  

Keywords:  Chinese medicine; Pseudomonas aeruginosa; Qiguiyin Decoction; multidrug-resistant; peptide array

Mesh:

Substances:

Year:  2015        PMID: 26424290     DOI: 10.1007/s11655-015-2089-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  4 in total

1.  [Viewing from the toll-like receptor/nuclear factor-kappaB signaling pathway to explore the immunomodulatory mechanism of Chinese drugs].

Authors:  Hong-guang Zhou; Hai-bin Chen; Mian-hua Wu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2010-08

2.  [Evaluation of immune regulation effects of Chinese medicinal formulae based on immunomics of traditional Chinese medicine].

Authors:  Hui Liu; Yue-Qiu Guo
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2008-12

3.  Impact of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species on clinical outcomes and hospital costs: a matched cohort study.

Authors:  Su Young Lee; Srividya Kotapati; Joseph L Kuti; Charles H Nightingale; David P Nicolau
Journal:  Infect Control Hosp Epidemiol       Date:  2006-10-23       Impact factor: 3.254

4.  Alteration of murine immune response by Pseudomonas aeruginosa exotoxin A.

Authors:  P S Holt; M L Misfeldt
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.609

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.